Old Web
English
Sign In
Acemap
>
Paper
>
Profast: Clincal and cost related benefits of ERAS in advanced ovarian cancer, a randomized trial
Profast: Clincal and cost related benefits of ERAS in advanced ovarian cancer, a randomized trial
2017
Melchor Carbonell-Socias
José-Luis Sánchez-Iglesias
Asunción Pérez-Benavente
Berta Díaz-Feijoo
Silvia Cabrera
Silvia Franco
Javier de la Torre
Oriol Puig
Manuel García
Susana Manrique
Rosa Burgos
Monica Pamies
Teresa Balcells
Susana Serrano
Lola Rubio
Antonio Gil Moreno
Keywords:
Randomized controlled trial
Ovarian cancer
Gynecology
Medicine
advanced ovarian cancer
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]